Adverse Reactions to Contrast Media

Adverse Reactions to Contrast Media: Introduction & Types - Contrast Reaction Primer

• Adverse reactions: Undesirable effects post-contrast media (CM) administration, ranging from mild to life-threatening.
• Reaction Types:
  • Idiosyncratic (Anaphylactoid): Unpredictable, not dose-dependent, mimic allergy.
    • Examples: Urticaria, angioedema, bronchospasm, anaphylaxis.
  • Non-idiosyncratic (Chemotoxic/Physiologic): Dose-dependent, predictable, due to CM properties.
    • Examples: Warmth, nausea/vomiting, vasovagal reaction, CIN, cardiac arrhythmias.
• Major CM Classes:
  • Iodinated (X-ray/CT): High Osmolar (HOCM), Low Osmolar (LOCM), Iso-osmolar (IOCM).
  • Gadolinium-Based Contrast Agents (GBCAs) for MRI.

⭐ Non-ionic LOCM show ~5-fold ↓ idiosyncratic reaction risk vs. HOCM.

Adverse Reactions to Contrast Media: Risk Factors & Pathophysiology - Danger Zones Unmasked

• Key Risk Factors:

  • Previous contrast reaction (highest risk)
  • Asthma, severe allergies (atopy)
  • Renal impairment (e.g., eGFR < 30 mL/min/1.73m² for CIN)
  • Cardiac disease (e.g., heart failure)
  • Medications: Beta-blockers, NSAIDs, Metformin, IL-2
  • Contrast type: HOCM > LOCM > IOCM

• Pathophysiology:

  • Idiosyncratic (Anaphylactoid): Pseudoallergic. Direct mast cell/basophil degranulation. Not IgE-mediated (mostly). Dose-independent.
  • Non-idiosyncratic (Chemotoxic): Dose-dependent. Direct organ toxicity (e.g., CIN, cardiac effects). Due to osmolality, viscosity.

⭐ A prior moderate/severe contrast reaction increases repeat reaction risk by ~5-fold.

Adverse Reactions to Contrast Media: Acute Reaction Management - Code Red Contrast

CODE RED: Life-threatening reaction. Activate emergency protocol. Prioritize ABCs.

• Adjunctive Therapy (Post-stabilization/symptom-specific):
  • Corticosteroids: Hydrocortisone 100-200 mg IV.
  • Antihistamines: Diphenhydramine 25-50 mg IV/IM.

⭐ Epinephrine is the cornerstone for severe anaphylaxis; IM (anterolateral thigh) preferred initially for rapid effect.

Adverse Reactions to Contrast Media: Specific Syndromes & Prevention - Delayed Dangers & Defenses

• Contrast-Induced Nephropathy (CIN)
  • Path: AKI post-iodinated contrast. ↑SCr >25% or >0.5 mg/dL from baseline in 48-72 hrs.
  • Prevention:
    • Hydration: Isotonic saline (0.9% NaCl) 1-1.5 mL/kg/hr pre- & post-procedure.
    • Use Low-Osmolar (LOCM) or Iso-Osmolar Contrast Media (IOCM); minimize volume.
    • Hold nephrotoxic drugs (e.g., Metformin for 48 hrs if eGFR <60 mL/min/1.73m² or AKI).
• Nephrogenic Systemic Fibrosis (NSF)
  • Path: Rare, severe fibrosing disorder post-Gadolinium-Based Contrast Agents (GBCAs) in renal impairment (eGFR <30 mL/min/1.73m²).
  • Features: Symmetrical skin thickening, hardening, joint contractures.
  • Prevention: Screen eGFR. Avoid high-risk (Group I, linear) GBCAs if eGFR <30. Prefer macrocyclic GBCAs.

  ⭐ NSF is strongly associated with Group I (linear) GBCAs, like gadodiamide, in patients with eGFR <30 mL/min/1.73m².

• Iodine-Induced Thyroid Dysfunction
  • Jod-Basedow effect (hyperthyroidism) or Wolff-Chaikoff effect (hypothyroidism).
  • Risk: Pre-existing thyroid disease, iodine deficiency.
• Delayed Cutaneous Reactions
  • E.g., maculopapular rash, urticaria; typically 1 hour to 1 week post-contrast.

High‑Yield Points - ⚡ Biggest Takeaways

• Anaphylactoid: IgE-independent, common. Chemotoxic: dose-dependent.
• Highest risk: Previous moderate/severe reaction. Also asthma, atopy.
• Severe anaphylactoid reactions (bronchospasm, hypotension): Treat with epinephrine.
• CIN: ↑SCr >25% or >0.5 mg/dL in 48-72h. Prevent: IV hydration.
• NSF: Risk with GBCAs (esp. Group I) in severe renal impairment (eGFR <30).
• Premedication (steroids, H1-blockers) for prior moderate/severe reactions.
• Delayed reactions: Cutaneous (maculopapular rash), hours to 1 week later.